Verve Therapeutics, Inc. VERV
11.13 0.00 (+0.00%)
At closeJul 25, 2025, 4:00 PM EDT
11.13 Day range 11.13
52-week range unavailable
- YTD
- +97.34%
- 1 year
- +57.20%
Revenue & Expenses
Latest period ending Dec 31, 2024 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|
| 32.33M | 11.76M | 1.94M | 0 | 0 | |
| 32.33M | 11.76M | 1.94M | 0 | 0 | |
| 32.33M | 11.76M | 1.94M | 0 | 0 | |
| 260.99M | 234.88M | 167.63M | 87.07M | 40.63M | |
| 204.35M | 184.95M | 130.09M | 68.20M | 35.37M | |
| 56.65M | 49.94M | 37.53M | 18.86M | 5.26M | |
| -228.66M | -223.12M | -165.69M | -87.07M | -40.63M | |
| 349.00K | 275.00K | 53.00K | 0 | 0 | |
| -198.71M | -200.07M | -157.39M | -120.31M | -45.70M | |
| -198.71M | -200.07M | -157.39M | -120.31M | -45.70M | |
| -198.71M | -200.07M | -157.39M | -120.31M | -45.70M | |
| -198.71M | -200.07M | -157.39M | -120.31M | -45.70M | |
| -2.35 | -3.12 | -2.91 | -4.48 | -20.31 | |
| -2.35 | -3.12 | -2.91 | -4.48 | -20.31 | |
| -2.35 | -3.12 | -2.91 | -4.48 | -20.31 | |
| -198.36M | -199.79M | -157.33M | -120.31M | -45.70M | |
| -198.36M | -199.79M | -157.33M | -120.31M | -45.70M | |
| 84.72M | 64.18M | 54.02M | 26.87M | 2.25M | |
| 84.72M | 64.18M | 54.02M | 26.87M | 2.25M |